Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001084431 | SCV001113624 | benign | Glucose-6-phosphate transport defect | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000966318 | SCV001148476 | uncertain significance | not provided | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001084431 | SCV001457214 | uncertain significance | Glucose-6-phosphate transport defect | 2020-04-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003972853 | SCV004786956 | likely benign | SLC37A4-related disorder | 2022-02-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |